Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer

被引：0
|
作者：
Sheng Zhang
Yongzhi Yang
Wenhao Weng
Bomin Guo
Guoxiang Cai
Yanlei Ma
Sanjun Cai
机构：
[1] Fudan University Shanghai Cancer Center,Department of Colorectal Surgery
[2] Fudan University,Department of Oncology, Shanghai Medical College
[3] Tongji University School of Medicine,Department of Clinical Laboratory, Yangpu Hospital
[4] Tongji University School of Medicine,Center for Translational Medicine, Yangpu Hospital
[5] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Surgery
来源：
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词：
BIRC3; 5-fluorouracil; Chemoresistance; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Integrin β1 mediates 5-fluorouracil chemoresistance under translational control of eIF4E in colorectal cancer
    Niu, Zhengchuan
    Xu, Pingping
    Zhu, Dexiang
    Tang, Wentao
    Ji, Meiling
    Lin, Qi
    Liu, Tianyu
    Ren, Li
    Wei, Ye
    Xu, Jianmin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (10): : 4771 - +
  • [22] Differential effects of 5-fluorouracil and oxaliplatin on autophagy in chemoresistant colorectal cancer cells
    Zitkute, Vilmante
    Kukcinaviciute, Egle
    Jonusiene, Violeta
    Starkuviene, Vytaute
    Sasnauskiene, Ausra
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (06) : 1103 - 1115
  • [23] Inhibition of heat shock protein 27 phosphorylation promotes sensitivity to 5-fluorouracil in colorectal cancer cells
    Matsunaga, Atsushi
    Ishii, Yoshiyuki
    Tsuruta, Masashi
    Okabayashi, Koji
    Hasegawa, Hirotoshi
    Kitagawa, Yuko
    ONCOLOGY LETTERS, 2014, 8 (06) : 2496 - 2500
  • [24] PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil
    Schoeckel, Leah
    Woischke, Christine
    Surendran, Sai Agash
    Michl, Marlies
    Schiergens, Tobias
    Hoelscher, Andreas
    Glass, Florian
    Kreissl, Peter
    Klauschen, Frederick
    Guenther, Michael
    Ormanns, Steffen
    Neumann, Jens
    BMC CANCER, 2024, 24 (01)
  • [25] Oral status in patients receiving 5-fluorouracil for colorectal cancer
    Djuric, M.
    Cakic, S.
    Hadzi-Mihailovic, M.
    Petrovic, D.
    Jankovic, L.
    JOURNAL OF BUON, 2010, 15 (03): : 475 - 479
  • [26] INTRAPERITONEAL 5-FLUOROURACIL IN THE MANAGEMENT OF COLORECTAL LIVER-CANCER
    ANDERSSON, R
    HOLMBERG, A
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1992, 18 (02): : 152 - 155
  • [27] Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model
    Li Tao
    Jin-Kun Yang
    Ying Gu
    Xin Zhou
    Ai-Guang Zhao
    Jian Zheng
    Ying-Jie Zhu
    World Journal of Gastroenterology, 2015, 21 (04) : 1125 - 1139
  • [28] 5-Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
    Alzahrani, Shiekhah M.
    Al Doghaither, Huda A.
    Al-Ghafari, Ayat B.
    Pushparaj, Peter N.
    ONCOLOGY REPORTS, 2023, 50 (04)
  • [29] Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model
    Tao, Li
    Yang, Jin-Kun
    Gu, Ying
    Zhou, Xin
    Zhao, Ai-Guang
    Zheng, Jian
    Zhu, Ying-Jie
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (04) : 1125 - 1139
  • [30] FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis
    He, Zhanke
    Yang, Junbo
    Sui, Chuyang
    Zhang, Penghao
    Wang, Ting
    Mou, Tingyu
    Sun, Kai
    Wang, Yanan
    Xu, Zhijun
    Li, Guoxin
    Deng, Haijun
    Shi, Jiaolong
    Zhuang, Baoxiong
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2022, 722
12345